CDK4/6 Inhibitor Palbociclib for Treatment of KMT2A-Rearranged Acute Myeloid Leukemia: Interim Analysis of the AMLSG 23-14 Trial

被引：13

作者：

Froehling, Stefan ^{[1
,2
]}

Agrawal, Mridul ^{[3
]}

Jahn, Nikolaus ^{[3
]}

Fransecky, Lars R. ^{[4
]}

Baldus, Claudia D. ^{[4
]}

Waesch, Ralph ^{[5
,6
]}

Luebbert, Michael ^{[7
]}

Walter, Gina ^{[8
]}

Jensen, Patrizia ^{[8
]}

Scholl, Claudia ^{[1
,2
]}

Habdank, Marianne ^{[9
]}

Doehner, Konstanze ^{[3
]}

Doehner, Hartmut ^{[3
]}

Schlenk, Richard F. ^{[8
,10
]}

机构：

[1] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany

[2] German Canc Res Ctr, Heidelberg, Germany

[3] Univ Hosp Ulm, Dept Internal Med III, Ulm, Germany

[4] Charite Univ Sch Med, Dept Hematol Oncol & Tumorimmunol, Berlin, Germany

[5] Univ Med Ctr Freiburg, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany

[6] Univ Med Ctr Freiburg, Comprehens Canc Ctr Freiburg, Freiburg, Germany

[7] Med Ctr Univ Freiburg, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany

[8] Heidelberg Univ, Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[9] Univ Hosp Ulm, Internal Med III, Ulm, Germany

[10] Univ Hosp Ulm, Ulm, Germany

来源：

关键词：

D O I：

10.1182/blood.V128.22.1608.1608

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1608

引用

页数：4